| Literature DB >> 28364549 |
Ortal Barel1,2, May Christine V Malicdan3,4, Bruria Ben-Zeev2,5,6, Judith Kandel7, Hadass Pri-Chen3,5, Joshi Stephen3, Inês G Castro8, Jeremy Metz8, Osama Atawa9, Sharon Moshkovitz1,2, Esther Ganelin5,6, Iris Barshack5,10, Sylvie Polak-Charcon5,10, Dvora Nass5,10, Dina Marek-Yagel2,5,11, Ninette Amariglio1,2, Nechama Shalva5,11, Thierry Vilboux3,12, Carlos Ferreira3,13, Ben Pode-Shakked5,11,14, Gali Heimer5,6,14, Chen Hoffmann5,15, Tal Yardeni16, Andreea Nissenkorn5,17, Camila Avivi10, Eran Eyal1,2, Nitzan Kol1,2, Efrat Glick Saar1,2, Douglas C Wallace16, William A Gahl3,4, Gideon Rechavi1,2,5, Michael Schrader8, David M Eckmann7,18,19, Yair Anikster2,5,11.
Abstract
Cellular distribution and dynamics of mitochondria are regulated by several motor proteins and a microtubule network. In neurons, mitochondrial trafficking is crucial because of high energy needs and calcium ion buffering along axons to synapses during neurotransmission. The trafficking kinesin proteins (TRAKs) are well characterized for their role in lysosomal and mitochondrial trafficking in cells, especially neurons. Using whole exome sequencing, we identified homozygous truncating variants in TRAK1 (NM_001042646:c.287-2A > C), in six lethal encephalopathic patients from three unrelated families. The pathogenic variant results in aberrant splicing and significantly reduced gene expression at the RNA and protein levels. In comparison with normal cells, TRAK1-deficient fibroblasts showed irregular mitochondrial distribution, altered mitochondrial motility, reduced mitochondrial membrane potential, and diminished mitochondrial respiration. This study confirms the role of TRAK1 in mitochondrial dynamics and constitutes the first report of this gene in association with a severe neurodevelopmental disorder. © Published by Oxford University Press on behalf of the Guarantors of Brain 2017. This work is written by US Government employees and is in the public domain in the US.Entities:
Keywords: TRAK1; early-onset epilepsy; mitochondria transport; neurodegeneration; rare diseases
Mesh:
Substances:
Year: 2017 PMID: 28364549 PMCID: PMC6075218 DOI: 10.1093/brain/awx002
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501